from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1602/hisH

LFCtreatmentdescriptionclass of inhibitor

-1.452

Amikacinug/mL Amikacintranslation

-1.320

Cap5-10ug/mL Capreomycintranslation

-1.649

Rox10-50 ug/mL Roxithromycintranslation

-0.490

SM2-5 ug/mL Streptomycintranslation

-0.779

Tet5-10 ug/mL Tetracyclinetranslation

0.276

Rif0.2-5ug/mL Rifampicintranscription

-0.520

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.384

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.253

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.231

CPZ10-50 ug/mL Chlorpromazinerespiration

0.438

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.074

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

3.741

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.438

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.626

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.304

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.544

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.368

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.727

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.007

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

4.003

KCN5-20 ug/mL Potassium cyaniderespiration

-1.178

NaN30.2-2 mM Sodium aziderespiration

-0.073

Nigericin50 uM Nigericinrespiration

0.004

TRC10-150 ug/mL Triclosanrespiration

0.329

TRZ10-25 ug/mL Thioridazinerespiration

0.306

Valinomycin0.5-10 uM Valinomycinrespiration

-1.633

ZnSO42 mM ZnSO4respiration

0.196

menadione6-10 ug/mL Menadionerespiration

-0.504

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.490

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.256

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.649

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.235

NRP_1Non-replicating persistence stage 1dosRassociated

-0.506

Amp0.2mg/mL AmpicillincellWall

-0.149

Cephalexin20-100 ug/mL CephalexincellWall

-0.051

Cerulenin0.32-5 ug/mL CerulenincellWall

0.142

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.010

EMB10-20 ug/mL EthambutolcellWall

0.119

Eta12-40 ug/mL EthionamidecellWall

0.317

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.299

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.493

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.556

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.116

BZA0.12 mg/mL BenzamidearomaticAmides

-0.060

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.244

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.118

H2O24 mM hydrogen peroxideDNAdamaging

-0.340

Levo10 ug/mL LevofloxacinDNAdamaging

-0.009

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.261

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.216

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.068

UVUV-irradiationDNAdamaging

0.591

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.706

Antimycin12.5-50 ug/mL Antimycin A?

-0.408

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.207

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.484

PA_2110-50 ug/mL Antitubercular compound PA-21?

2.538

PA8240.2-2 ug/mL PA-824?

2.011

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.723

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.377

Verapamil50 uM Verapamil?

-0.529

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.426

methoxatin10-20 ug/mL Methoxatin?